Many years ago Sanofi-Synthelabo, a French Pharmaceutical Company created a medication called Acomplia (Rimonabant) . This is a new medical treatment in the fight against obesity and possibly other health ailments.
Rimonabant is available in many different European countries. It was officially approved in Britain on June 28th 2006. Acomplia is available as a non-prescription weight loss pill in the United Kingdom. It then went on to be approved by several other countries in Europe and around the world like Ireland, Belgium, Germany, Norway, Sweden, Denmark and Finland. But it does not have approval from the United States Food and Drug Administration (FDA), and is not available in the USA. Some believe this could one day make its way to the United Stated, but there are no 'for sures' on this one.
Acomplia (Rimonabant) diet pills are offering hope for individuals needing help with their obesity. Perhaps in a way that other medications could not provide or did so in a way where the side effects were not wanted. This medication as with any comes with stated side effects that one may or may not have while taking the product.
Acomplia actually works in a different method than other weight loss pills, and has other potential benefits as well that other weight loss medications do not. Studies also show that it increases levels of HDL (good cholesterol) while at the same time reduces the triglycerides (bad cholesterol). It holds some promise for type 2 diabetes as well as taking away the craving for cigarettes.
Acomplia Rimonabant mechanism of action
Rimonabant is considered to be an appetite suppressant. It works by blocking a cellular receptor in the endocannabinoid system of the brain, believed to influence the regulation of body weight, glucose and lipid metabolism. In doing so it is believed that this regulation then reduces the craving to eat more.
Clinical Studies have shown that 33% of people taking Rimonabant lost 10% of body weight and kept their weight down for two years which is extremely newsworthy as no other diet drug has accomplished this for so long a period. It also holds huge potential for the obese individual who have other health problems.Rimonabant is available in many different European countries. It was officially approved in Britain on June 28th 2006. Acomplia is available as a non-prescription weight loss pill in the United Kingdom. It then went on to be approved by several other countries in Europe and around the world like Ireland, Belgium, Germany, Norway, Sweden, Denmark and Finland. But it does not have approval from the United States Food and Drug Administration (FDA), and is not available in the USA. Some believe this could one day make its way to the United Stated, but there are no 'for sures' on this one.
Acomplia (Rimonabant) diet pills are offering hope for individuals needing help with their obesity. Perhaps in a way that other medications could not provide or did so in a way where the side effects were not wanted. This medication as with any comes with stated side effects that one may or may not have while taking the product.
Acomplia actually works in a different method than other weight loss pills, and has other potential benefits as well that other weight loss medications do not. Studies also show that it increases levels of HDL (good cholesterol) while at the same time reduces the triglycerides (bad cholesterol). It holds some promise for type 2 diabetes as well as taking away the craving for cigarettes.
Acomplia Rimonabant mechanism of action
Rimonabant is considered to be an appetite suppressant. It works by blocking a cellular receptor in the endocannabinoid system of the brain, believed to influence the regulation of body weight, glucose and lipid metabolism. In doing so it is believed that this regulation then reduces the craving to eat more.
No comments:
Post a Comment